Universal Health Services (UHS) stock
Health Care · Health Care Facilities
Universal Health Services (UHS) is a Health Care Facilities company in the Health Care sector, headquartered in King of Prussia, Pennsylvania. As of October 23, 2026, UHS closed at $186.89, a market capitalization of $11.01 billion, the 487th largest company in the S&P 500. Over the last twelve months it generated $18.11 billion in revenue (+8% year over year) and $810.74 million in free cash flow. The stock trades at 7.4x trailing earnings and 7.8x forward earnings.
- 1-year total return: -10.0% (dividends reinvested)
- 5-year return: +7.2% a year
- 52-week range: $140.08 – $246.33
- Gross margin 44.6%, operating margin 11.1%
- Dividend yield: 0.43%
- FI Handbook report card: B- across 10 metrics
- 57th largest of 60 Health Care stocks in the S&P 500
UHS price chart
1Y price change: -10.4% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| UHS | +3.0% | -14.0% | -10.0% | +14.9% | +7.2% | +4.7% | +12.0% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 1981.
UHS key statistics
- Market cap
- $11.0B
- #487 in S&P 500
- P/E (TTM)
- 7.4x
- Forward P/E
- 7.8x
- EPS (TTM)
- $25.23
- Revenue (TTM)
- $18.1B
- +8%
- Free cash flow
- $810.7M
- Gross margin
- 44.6%
- Operating margin
- 11.1%
- Return on equity
- 20.9%
- Dividend yield
- 0.43%
- 52-week range
- $140.08 – $246.33
- Beta
- 1.03
- Price / sales
- 0.6x
- EV / EBITDA
- 6.0x
- Debt / equity
- 0.69x
- Employees
- 102,000
UHS report card
B-Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth8.3%C
- Gross margin44.6%B
- Operating margin11.1%C
- FCF margin4.5%D
- Return on equity20.9%B
- Net debt / EBITDA1.9xC
- Forward P/E7.8xA
- PEG ratio1.2xB
- Shareholder yield9.2%A
- Share count change / yr-5.5%A
Universal Health Services financials
Revenue went from $9.8B in fiscal 2016 to $17.4B in fiscal 2025, growing 6.6% a year.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.8B | $10.4B | $10.8B | $11.4B | $11.6B | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Operating income | $1.3B | $1.3B | $1.2B | $1.2B | $1.4B | $1.4B | $1.0B | $1.2B | $1.7B | $2.0B |
| Net income | $702.4M | $752.3M | $779.7M | $814.9M | $944.0M | $991.6M | $675.6M | $717.8M | $1.1B | $1.5B |
| EPS (diluted) | $7.14 | $7.81 | $8.31 | $9.13 | $10.99 | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 |
| Free cash flow | $813.9M | $690.1M | $609.8M | $804.4M | $1.6B | $28.0M | $262.0M | $524.7M | $1.1B | $849.2M |
| Buybacks | $353.4M | $364.4M | $397.4M | $770.5M | $206.7M | $1.2B | $832.9M | $547.4M | $670.8M | $968.0M |
| Dividends paid | $38.9M | $38.2M | $37.3M | $53.0M | $17.3M | $65.9M | $58.4M | $55.5M | $53.3M | $51.3M |
| Diluted shares | 98.4M | 96.3M | 93.8M | 89.0M | 85.6M | 83.7M | 73.8M | 70.1M | 67.9M | 64.5M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into UHS?
A reverse DCF asks what growth the current price requires. With an enterprise value of $16.1B and $810.7M of trailing free cash flow, Universal Health Services needs to grow free cash flow about 10.4% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew -12.2% a year over the last five years.
P/E ratio history
Current 8.1x vs. median 15.5x (10th–90th percentile 10.3x–21.1x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
UHS dividend
- Dividend yield
- 0.43%
- Annual dividend
- $0.80
- Years of increases
- —
- 5-yr dividend growth
- 32.0%
- per year
- Payout ratio
- 3%
- Payments per year
- 4
Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.
UHS analyst price targets
17 analysts' average 12-month target is $196.12 (+5% vs. $186.89). Targets range from $166.00 to $290.00. 30% rate it a buy.
UHS earnings
Next report: October 27, 2026. Last quarter's revenue was $4.6B (+8% year over year).
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 27, 2026 | $6.01 | $5.98 | -0.5% |
| Apr 27, 2026 | $5.46 | $5.62 | +3.0% |
| Feb 25, 2026 | $5.91 | $5.88 | -0.5% |
| Oct 27, 2025 | $4.95 | $5.69 | +14.9% |
| Jul 28, 2025 | $4.96 | $5.35 | +8.0% |
| Apr 28, 2025 | $4.36 | $4.84 | +11.1% |
| Feb 26, 2025 | $4.18 | $4.92 | +17.8% |
| Oct 24, 2024 | $3.70 | $3.71 | +0.3% |
Stocks like UHS
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 HCA HCA Healthcare | +0.37% | +7% | $101.5B | 15.7x | Compare |
 LLY Eli Lilly and | -2.54% | +56% | $1.1T | 42.7x | Compare |
 JNJ Johnson & Johnson | -1.42% | +40% | $635.1B | 40.0x | Compare |
 ABBV AbbVie | +0.16% | +29% | $504.8B | 80.7x | Compare |
 UNH UnitedHealth | -1.62% | +19% | $375.3B | 26.9x | Compare |
 MRK Merck & | -1.34% | +72% | $358.4B | 117.2x | Compare |
 TMO Thermo Fisher Scientific | -0.40% | +18% | $249.1B | 35.5x | Compare |
 AMGN Amgen | -1.79% | +54% | $237.5B | 27.3x | Compare |
UHS news
- Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings? · Oct 21, 2026
- Analysts Estimate Universal Health Services (UHS) to Report a Decline in Earnings: What to Look Out for · Oct 20, 2026
- Earnings Preview: What to Expect From Universal Health Services’ Report · Oct 12, 2026
- Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call · Oct 9, 2026
- Is Universal Health Services (UHS) Trading At A Discount After Talkspace? · Oct 8, 2026
UHS stock FAQ
What is UHS's market cap?
Universal Health Services's market capitalization is $11.01 billion as of October 23, 2026, ranking 487th in the S&P 500.
What is UHS's P/E ratio?
UHS trades at a trailing price-to-earnings ratio of 7.4x and a forward P/E of 7.8x. Its median P/E over the period we track is 15.5x.
Does UHS pay a dividend?
Yes. Universal Health Services pays $0.80 per share a year, a 0.43% yield. Dividends grew 32.0% a year over the last five years.
How much has UHS stock returned?
Including reinvested dividends, UHS returned -10.0% over one year, +7.2% a year over five years, +4.7% a year over ten years through October 23, 2026.
Is UHS stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Universal Health Services must grow free cash flow about 10% a year for the next decade. Its free cash flow fell 12% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the UHS price target?
17 analysts cover UHS with an average 12-month price target of $196.12, +5% from the current price. 30% of them rate it a buy.
When does UHS report earnings?
Universal Health Services is expected to report earnings on October 27, 2026.
How many employees does Universal Health Services have?
Universal Health Services has about 102,000 full-time employees, or $177,593 of revenue per employee.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology